According to GlobalData’s medical device pipeline database, 46 Structural Heart Occluders devices are in various stages of development globally. GlobalData’s report Structural Heart Occluders provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 34 are in active development, while the remaining 16 are in an inactive stage of development. There are 14 products in the early stages of development, and the remaining 20 are in the late stages of development.
Cardiovascular Devices are used to detect and treat heart and circulatory system related diseases. Structural Heart Occluders are used to treat atrial septal defect (ASD) and patent foramen ovale (PFO) by closing the holes in the heart. It includes Atrial Septal Defect Occluders, Ventricular Septal Defect Occluders, Patent Ductus Arteriosus Closure Devices, Patent Foramen Ovale Closure Devices and Left Atrial Appendage Closure Devices.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Structural Heart Occluders pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Structural Heart Occluders devices. Overall, most of these Structural Heart Occluders pipeline devices are being developed by private entities.
Key players involved in the active development of Structural Heart Occluders include Lepu Scientech Medical Technology (Shanghai), Occlutech International, SentreHEART, Endomimetics, Hansen Medical, Laminar, Ension, Guangdong Pulse Medical Technology, Hangzhou Dinova EP Technology and SeptRx.
For a complete picture of the developmental pipeline for Structural Heart Occluders devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.